Chasteberry for PMS: Evidence, Dose and Safety

Chasteberry—also called vitex or Vitex agnus-castus—is often marketed as a general “hormone balancer.” That phrase is too loose to guide a real decision. Hormones are not one dial, premenstrual symptoms have many possible causes, and an herb should not be treated as a shortcut around diagnosis. The useful questions are narrower: what is this exact extract licensed for, what did human trials actually test, how long should someone assess it, and when is it a poor choice?

What is chasteberry?

Chasteberry is the fruit of Vitex agnus-castus, a shrub native to the Mediterranean and Central Asia. It has a long history of use for menstrual complaints. Modern research has focused mainly on premenstrual syndrome (PMS), including combinations of irritability, mood changes, headache, breast tenderness or fullness, bloating and other recurring symptoms before menstruation.

Researchers have proposed effects involving dopamine signalling and prolactin regulation, but the mechanism in humans is not fully settled. A plausible pathway is not the same as proof of symptom relief, and “supports hormone balance” should not be stretched into claims about fertility, polycystic ovary syndrome, menopause, endometriosis, thyroid disease or a specific laboratory hormone result.

What is in Biogénique Chasteberry?

The controlled Canadian product licence identifies one medicinal ingredient: 100 mg of Vitex agnus-castus fruit extract per capsule, equivalent to 1,000 mg of dried fruit. That amount corresponds to a 10:1 dry-herb equivalence. The licence and current live page agree on the 100 mg extract and 1,000 mg dried-fruit equivalent. NPN 80132073 appears on the bottle art and in the licence, although the page’s dedicated NPN header was blank when reviewed.

The controlled record lists non-medicinal ingredients as “N/A,” while the live page calls the capsule vegetarian and marketing material adds vegan and non-GMO language. Those claims are not repeated here because the complete current non-medicinal ingredient list was not available in the controlled package reviewed. People with allergies, dietary restrictions or capsule-material concerns should check the physical label before use.

What does the Canadian licence support?

The product-specific licensed use is precise: “Used in Herbal Medicine (as a hormone normaliser) to help stabilise menstrual cycle irregularities and relieve premenstrual symptoms.” This wording supports a PMS and cycle-irregularity article. It does not turn the product into a general treatment for every condition associated with hormones or menstruation.

The licensed dose is also specific: women 18 years and older take one capsule once daily. The recommended duration says to use it for at least three months to see beneficial effects. That timeline matters. Chasteberry is not positioned as an instant rescue product for a single difficult day, and changing the dose after a week would not follow the licence.

Does chasteberry help PMS?

The best answer is “possibly, for some people, with important evidence limits.” Several randomized trials report symptom improvement, and a stricter meta-analysis found a higher likelihood of response than placebo. At the same time, reviews repeatedly identify high risk of bias, inconsistent outcome measures, publication bias and major differences among extracts. None of the studies below tested this exact finished Biogénique product.

The 2001 study illustrates both the promise and the comparability problem. Its tablet contained 20 mg of Ze 440, an ethanolic extract with a defined drug-to-extract ratio and casticin standardization. Biogénique’s licence lists 100 mg of extract equivalent to 1,000 mg dried fruit but does not identify Ze 440, the same extraction solvent or the same marker standardization. Milligrams of different botanical extracts are not interchangeable. It would be misleading to call the Biogénique capsule “five times the trial dose.”

How long does chasteberry take to work?

Biogénique’s licence says to use the product for at least three months to see beneficial effects. Major trials also assessed treatment across multiple menstrual cycles rather than after one or two doses. A practical evaluation therefore needs a baseline and a repeatable symptom record across cycles.

Before starting, record the timing and severity of the symptoms that matter most—such as irritability, headache, breast tenderness or bloating—and note how they affect daily function. Keep the rest of the routine reasonably stable. After three cycles, the relevant question is not “Did I feel anything?” but “Did the same premenstrual pattern become meaningfully less severe or disruptive?” If symptoms persist or worsen, the label says to consult a health care professional.

Who should not use this product?

Do not use Biogénique Chasteberry if you are pregnant, breastfeeding or attempting to conceive unless you have consulted a health care practitioner. Health Canada highlighted this precaution in its July 2024 safety communication after updating the chaste tree monograph. The restriction should be stated prominently because fertility marketing can pull consumers in exactly the wrong direction.

The licence also says to consult a health care practitioner before use if you take hormone-containing medicines such as progesterone preparations, oral contraceptives or hormone replacement therapy. Do not assume that “natural” means compatible with birth control or hormone therapy. People with hormone-sensitive conditions or a complex medication plan should obtain individualized advice before use.

Side effects and when to stop

NCCIH reports that chasteberry fruit extract is generally well tolerated in short-term research up to three months. Reported effects are usually mild and can include nausea, stomach pain, diarrhea, headache or itching. Individual products and populations differ, so this is safety context—not a promise that side effects will be mild for every user.

Stop use and seek urgent care for signs of a severe allergic reaction, including facial swelling, breathing difficulty or trouble swallowing. Seek professional assessment for a major change in bleeding, severe pelvic pain, new neurological symptoms, possible pregnancy, or symptoms that are persistent, worsening or affecting normal function. A supplement should not delay evaluation of an underlying gynecologic, endocrine or medication-related cause.

Is chasteberry proven for fertility, PCOS or menopause?

No reliable conclusion for those uses can be transferred from the PMS evidence. NCCIH says there is not enough reliable evidence to know whether chasteberry helps infertility and notes that use during pregnancy may be unsafe. Evidence for menopausal symptoms is preliminary. Biogénique’s product licence does not authorize fertility, PCOS, menopause, prolactin-lowering or pregnancy-support claims.

That distinction is especially important online, where cycle irregularity is often treated as a diagnosis. Irregular cycles can have many causes. If the goal is conception, if cycles have changed substantially, or if symptoms suggest a medical condition, the next step is assessment—not adding a “hormone balance” product without context.

What should a credible chasteberry quality claim show?

Botanical evidence depends on identity: plant species, plant part, extraction ratio, extraction solvent and chemical standardization can all influence the preparation. A credible finished-product package should also connect the bottle’s lot to specifications and results for identity, potency and relevant contaminants. A generic quality video or company-level statement is not a certificate for the bottle in hand.

The live page says the product is tested for purity, potency, heavy metals, absorption and microbiological safety, and the bottle art uses “PHARMACEUTICAL GRADE.” No readable, product-specific finished-product COA was located in the connected records reviewed for this draft. This article therefore makes no current-lot testing claim and does not use “pharmaceutical grade.” Stronger quality wording should wait for a named standard and a readable lot-matched certificate with specifications, methods or limits, actual results and release decision.

A practical decision framework

1. Name the target. This product is licensed for premenstrual symptoms and menstrual cycle irregularities—not general hormone optimization.

2. Match the exact product. Verify NPN 80132073, 100 mg of Vitex agnus-castus fruit extract and the 1,000 mg dried-fruit equivalent on the current label.

3. Screen the exclusions. Pregnancy, breastfeeding, attempting to conceive and hormone-containing medicines require the label’s stated precautions.

4. Use the labelled timeline. Take one capsule once daily and assess over at least three months; do not increase the dose to imitate a different extract used in research.

5. Track a small set of recurring symptoms by cycle. If there is no meaningful benefit, symptoms worsen or the pattern changes, seek professional assessment.

6. Require evidence for quality superlatives. A current lot certificate is more informative than an undefined “grade,” a generic testing statement or a marketing seal.

Frequently asked questions

What are the benefits of chasteberry?

For this exact product, the licensed use is to help stabilise menstrual cycle irregularities and relieve premenstrual symptoms. Human evidence is promising for PMS but varies by extract and study quality. Broader claims about fertility, PCOS, menopause or universal hormone balance are not established for this formula.

How much Biogénique Chasteberry should I take?

Women 18 years and older take one capsule once daily. Each capsule supplies 100 mg of chasteberry fruit extract, equivalent to 1,000 mg dried fruit. Follow the current label and do not convert doses from a study of a different standardized extract.

When should I take chasteberry?

The product licence specifies once-daily use but does not require a particular time of day or state that it must be taken with food. Choose a consistent time that supports adherence unless a clinician or the current physical label gives a different instruction.

How long should I try it?

The licensed duration says to use it for at least three months to see beneficial effects. Track symptoms across cycles and consult a health care professional if they persist or worsen. Continuing indefinitely without reassessment is not the same as following an evidence-based plan.

Can I take chasteberry with birth control?

Do not make that decision from a generic interaction checker. The licence says to consult a health care practitioner before use with hormone-containing medicines, explicitly including oral contraceptives, progesterone preparations and hormone replacement therapy.

Can I use chasteberry while trying to conceive?

Not without professional advice. The product licence says not to use it while attempting to conceive unless you have consulted a health care practitioner. The same restriction applies during pregnancy and breastfeeding.

Is a 100 mg extract stronger than a 20 mg trial extract?

That comparison cannot be made from milligrams alone. Botanical extracts can differ in plant-to-extract ratio, solvent, chemical markers and manufacturing process. The well-known 20 mg trial used a named standardized Ze 440 extract; the Biogénique licence does not establish equivalence to it.

The bottom line

Chasteberry has a credible, product-appropriate use for premenstrual symptoms, and several controlled trials support a possible benefit. The evidence is not strong enough to promise “balanced hormones,” and results from one standardized extract cannot be pasted onto every vitex capsule. Biogénique Chasteberry offers a simple licensed regimen—100 mg of fruit extract once daily, assessed for at least three months—but it also carries meaningful pregnancy and medication precautions. The responsible path is to use the exact label, track a specific cycle-related goal and demand product-specific evidence for any quality claim.

Related resources

• Biogénique Chasteberry — Current product formats and availability.

• Quality Control — Biogénique’s quality approach and certificate information.

• Research & Innovation — How Biogénique approaches formulation and evidence.

• VitaQuiz / Find My Formula — Explore products by broader wellness goals.

References

1. Health Canada. Licensed Natural Health Product record for Biogénique Chasteberry, NPN 80132073.

2. Biogénique controlled product licence. Biogénique Chasteberry, NPN 80132073. Issued 25 June 2024.

3. Biogénique. Chasteberry product page. Reviewed 26 August 2026.

4. Health Canada. Health Product InfoWatch: Chaste tree monograph update. July 2024.

5. Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study. BMJ. 2001;322:134-137. doi:10.1136/bmj.322.7279.134.

6. Verkaik S, et al. The treatment of premenstrual syndrome with preparations of Vitex agnus castus: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017;217(2):150-166. PMID: 28237870.

7. Csupor D, et al. Vitex agnus-castus in premenstrual syndrome: a meta-analysis of double-blind randomised controlled trials. Complement Ther Med. 2019;47:102190. doi:10.1016/j.ctim.2019.08.024.

8. National Center for Complementary and Integrative Health. Chasteberry: Usefulness and Safety. Accessed 26 August 2026.

Disclaimer